Glenmede Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7M Sell
276,832
-99,236
-26% -$8.01M 0.1% 175
2026
Q1
$32.6M Sell
376,068
-118,675
-24% -$11.4M 0.16% 118
2025
Q4
$47.5M Buy
+494,743
New +$48.1M 0.23% 88
2025
Q1
$47.1M Buy
523,800
+105,785
+25% +$9.47M 0.25% 84
2024
Q4
$33.4M Buy
418,015
+37,461
+10% +$3.24M 0.17% 115
2024
Q3
$34.3M Buy
380,554
+90,111
+31% +$7.58M 0.16% 124
2024
Q2
$22.9M Sell
290,443
-5,213
-2% -$427K 0.12% 171
2024
Q1
$25.8M Sell
295,656
-7,654
-3% -$653K 0.13% 163
2023
Q4
$25M Sell
303,310
-51,157
-14% -$3.9M 0.13% 166
2023
Q3
$27.8M Buy
354,467
+3,018
+0.9% +$253K 0.16% 134
2023
Q2
$28.3M Hold
351,449
0.16% 144
2023
Q1
$28.3M Buy
351,449
+117,976
+51% +$9.62M 0.16% 144
2022
Q4
$18.1M Sell
233,473
-105,842
-31% -$8.58M 0.11% 209
2022
Q3
$27.4M Buy
339,315
+7,005
+2% +$630K 0.17% 136
2022
Q2
$29.8M Sell
332,310
-7,689
-2% -$779K 0.17% 138
2022
Q1
$37.7M Buy
339,999
+9,890
+3% +$1.04M 0.19% 129
2021
Q4
$34.1M Sell
330,109
-12,759
-4% -$1.48M 0.16% 143
2021
Q3
$43M Buy
342,868
+1,653
+0.5% +$214K 0.22% 112
2021
Q2
$42.4M Sell
341,215
-306
-0.1% -$38.4K 0.22% 115
2021
Q1
$40.3M Buy
341,521
+92,626
+37% +$10.9M 0.22% 122
2020
Q4
$29.2M Sell
248,895
-1,315
-0.5% -$145K 0.16% 159
2020
Q3
$26M Sell
250,210
-340
-0.1% -$34.1K 0.16% 159
2020
Q2
$23M Sell
250,550
-226,526
-47% -$21.7M 0.14% 173
2020
Q1
$54.1M Hold
477,076
0.25% 111
2019
Q4
$54.1M Sell
477,076
-11,726
-2% -$1.29M 0.25% 111
2019
Q3
$53.1M Buy
488,802
+178,063
+57% +$18.6M 0.24% 115
2019
Q2
$30.3M Buy
310,739
+3,530
+1% +$322K 0.13% 220
2019
Q1
$28M Sell
307,209
-7,109
-2% -$636K 0.13% 247
2018
Q4
$28.6M Buy
314,318
+84,022
+36% +$7.85M 0.14% 220
2018
Q3
$22.7M Sell
230,296
-1,633
-0.7% -$151K 0.09% 306
2018
Q2
$19.9M Sell
231,929
-16,081
-6% -$1.34M 0.09% 304
2018
Q1
$20M Hold
248,010
0.08% 305
2017
Q4
$20M Sell
248,010
-16,643
-6% -$1.33M 0.08% 305
2017
Q3
$20.6M Sell
264,653
-3,643
-1% -$302K 0.09% 285
2017
Q2
$21.6M Hold
268,296
0.1% 278
2017
Q1
$21.6M Sell
268,296
-41,490
-13% -$3.24M 0.1% 278
2016
Q4
$22.1M Sell
309,786
-13,523
-4% -$1.06M 0.12% 274
2016
Q3
$27.9M Sell
323,309
-16,601
-5% -$1.45M 0.16% 227
2016
Q2
$29.5M Sell
339,910
-22,830
-6% -$1.85M 0.18% 199
2016
Q1
$27.2M Sell
362,740
-97,437
-21% -$7.34M 0.18% 196
2015
Q4
$35.4M Sell
460,177
-80,767
-15% -$6.08M 0.24% 112
2015
Q3
$36.2M Sell
540,944
-62,513
-10% -$4.6M 0.27% 103
2015
Q2
$44.7M Sell
603,457
-16,424
-3% -$1.25M 0.32% 73
2015
Q1
$48.3M Buy
619,881
+3,320
+0.5% +$252K 0.35% 66
2014
Q4
$44.5M Sell
616,561
-43,306
-7% -$3.01M 0.35% 57
2014
Q3
$40.9M Buy
659,867
+15,901
+2% +$1.01M 0.36% 57
2014
Q2
$41.1M Buy
643,966
+131,752
+26% +$8M 0.37% 57
2014
Q1
$31.5M Sell
512,214
-80,348
-14% -$4.68M 0.29% 74
2013
Q4
$34M Sell
592,562
-13,029
-2% -$739K 0.35% 60
2013
Q3
$32.2M Buy
605,591
+15,627
+3% +$841K 0.38% 60
2013
Q2
$30.4M Buy
+589,964
New +$29.2M 0.38% 60

Other funds holding MDT

Glenmede Trust's MDT Position: Q2 2026 in Review

Glenmede Trust reduced its Medtronic (MDT) stake by 26% in Q2 2026, selling an estimated $8.01M and leaving 276,832 shares worth $21.7M. The position accounts for 0.1% of the portfolio, ranked #175.

Glenmede Trust first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $54.1M in Q1 2020. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Glenmede Trust held 276,832 shares of Medtronic worth $21.7M as of Q2 2026.
  • Glenmede Trust sold 99,236 Medtronic shares in Q2 2026, an estimated $8.01M.
  • Medtronic made up 0.1% of Glenmede Trust's portfolio in Q2 2026, its #175 holding.
  • Glenmede Trust first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
  • Glenmede Trust's Medtronic position peaked at $54.1M in Q1 2020.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.